One day left: the King Review


clock time

Panel urges pharmacists, consumers and industry stakeholders to contribute their voice

Submissions close 11:59pm AEST, on Friday 23 September 2016.

Chair Professor Stephen King says the review panel has turned its attention to the next stage of the review – preparation of the Interim Report, which will contain the Panel’s draft recommendations.

“For this we need your submissions. Your submissions are important to provide the Panel with the evidence we need to make recommendations which will move community pharmacy forward in Australia,” he says.

“Submissions may focus on just one question from our Discussion Paper, or several questions. We will equally consider all submissions received before the closing date.”

So far 65 submissions have been received, covering a range of topics including pharmacist wages, pharmacy owners’ struggles, location rules, CAMs and more.

Previous Forum: 4 must ask questions when supplying medication
Next Most pharmacists want CPA negotiations to change: poll

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

5 Comments

  1. Tim Hewitt
    22/09/2016

    65 submissions is pretty poor.. anyone who does not submit can’t turn around and complain about either the current state of affairs, or any future problems! submit submit submit!!!

    • Big pharma
      22/09/2016

      Agreed. But the submissions page hasn’t been updated for a week

  2. Anne Todd
    23/09/2016

    There is also the survey for those that are a bit put off by the idea of a submission.

  3. Drugby
    23/09/2016
  4. TT
    24/09/2016

    Can only see one major group there (Priceline). Good on them. Everyone else tactically waiting until the last day? I have to say some very personal agendas are being pushed on some submissions. One from Lawley Pharmaceuticals is aimed squarely at compounding pharmacies & provides interesting reading. At the end of the day it will give the impression to the review panel that pharmacists and the industry are a divided lot and heavily money-focused and not interested so much in patient health. This was a missed opportunity, I fear, for the pharmacy industry to unite together as tightly as possible thereby providing a strong, unified front for upcoming negotiations.

Leave a reply